BIOMARIN PHARMACEUTICAL INC Stock Issued During Period, Shares, New Issues
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Stock Issued During Period, Shares, New Issues of 9.78 million shares for the 1-month period ending 2015-01-31, per its 10-Q filed 2015-11-02.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2015-11-02
- 2015-01-31: Stock Issued During Period, Shares, New Issues 1 month 9.78M shares.
- 2014-03-31: Stock Issued During Period, Shares, New Issues 1 month 1.50M shares.
- 2012-06-30: Stock Issued During Period, Shares, New Issues 1 month 6.50M shares.
| Period end | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|
| 2015-01-31 | 9.78M shares 10-Q · filed 2015-11-02 |
| 2014-03-31 | 1.50M shares 10-Q · filed 2014-05-02 |
| 2012-06-30 | 6.50M shares 10-Q · filed 2012-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |